Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Molecular Immunology|October 16, 2007
Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitopeSabrina Deroo, Aurélie Fischer, Nadia Beaupain, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2003
Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strainsFrançois Roman, Dimitri Gonzalez, Christine Lambert, et al.
AIDS Research and Human Retroviruses|February 6, 2015
Near Full-Length Characterization and Population Dynamics of the Human Immunodeficiency Virus Type I Circulating Recombinant Form 42 (CRF42_BF) in LuxembourgDaniel Struck, François Roman, Sébastien De Landtsheer, et al.
World Journal of Gastroenterology|February 27, 2008
Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006Francois Roman, Karin Hawotte, Daniel Struck, et al.
Current HIV Research|June 16, 2011
Evaluation of saliva as an alternative matrix for monitoring plasma Zidovudine, Lamivudine and nevirapine concentrations in RwandaAlain Gras, Serge Schneider, Jean-Claude Karasi, et al.
Plos One|September 7, 2016
The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell TransmissionEveline Santos da Silva, Martin Mulinge, Morgane Lemaire, et al.
Plos One|May 14, 2013
HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected]Martin Mulinge, Morgane Lemaire, Jean-Yves Servais, et al.
AIDS Reviews|May 19, 2011
European recommendations for the clinical use of HIV drug resistance testing: 2011 updateAnne-Mieke Vandamme, Ricardo J Camacho, Francesca Ceccherini-Silberstein, et al.
BMC Infectious Diseases|February 29, 2008
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg databaseJean Ruelle, François Roman, Anne-Thérèse Vandenbroucke, et al.
Journal of the International AIDS Society|September 6, 2019
Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surfaceVic Arendt, Mathieu Amand, Gilles Iserentant, et al.
Pageof 6